Tag Archives : Wegener’s

VF Partners with Northwestern University to Open Vasculitis Program

The Vasculitis Foundation and Northwestern Memorial Hospital’s Division of Rheumatology have launched the health system’s first Vasculitis Clinical Research Program. Vasculitis is an immune system disorder that causes destructive inflammation more »


Read More

Breakthrough Therapy for Patients with Giant Cell Arteritis

FDA Grants Breakthrough Therapy Designation for GENENTECH’S Actemra® (tocilizumab) in Giant Cell Arteritis, A form of vasculitis Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced more »


Read More

Support the VF through the Amazon Smile Program

Just in time for your holiday shopping! AmazonSmile is a simple and automatic way for you to support the Vasculitis Foundation every time you shop, at no cost to you. more »


Read More

Brandon Qualifies for the 1500m Semi-Finals – Competes July 8th

Brandon Hudgins, elite runner, and vasculitis patient, continues his quest to make the 2016 U.S. Olympic Team!  On Thursday, July 7th, Brandon qualified for the semi-finals of the 1500m race more »


Read More

KU Vasculitis Symposium – August 6 – Register Today

The Vasculitis Foundation is pleased to partner with the University of Kansas Medical Center to present the 2016 Vasculitis Symposium Educational Conference.  The one-day meeting will be held on Saturday, more »


Read More